tiprankstipranks
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
US Market
SLNO
Soleno Therapeutics
RESEARCH TOOLSreports
Want to see SLNO full AI Analyst Report?

Soleno Therapeutics (SLNO) Income Statement

926 Followers

Soleno Therapeutics Income Statement

Last quarter (Q4 2025), Soleno Therapeutics's total revenue was $91.73M, an increase of Infinity% from the same quarter last year. In Q4, Soleno Therapeutics's net income was $43.36M. See Soleno Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 190.41M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 187.71M$ 0.00$ -1.96M$ 0.00$ 0.00
Operating Expenses
$ 172.75M$ 187.67M$ 41.38M$ 24.40M$ 31.53M
Depreciation and Amortization
$ 2.02M$ 1.99M$ 1.96M$ 1.96M$ 1.96M
EBITDA
$ 28.38M$ -173.63M$ -37.03M$ -22.10M$ -30.30M
Operating Income
$ 14.95M$ -187.67M$ -41.38M$ -24.40M$ -31.53M
Other Income/Expenses
$ 5.94M$ 11.82M$ 2.40M$ 330.00K$ 618.00K
Pretax Income
$ 20.89M$ -175.85M$ -38.99M$ -24.07M$ -30.91M
Net Income
$ 20.89M$ -175.85M$ -38.99M$ -24.07M$ -30.91M
Per Share Metrics
Basic EPS
$ 0.41$ -4.38$ -2.36$ -2.87$ -5.81
Diluted EPS
$ 0.39$ -4.38$ -2.36$ -2.87$ -5.81
Weighted Average Shares Outstanding
 53.18M 40.18M 16.49M 8.40M 5.32M
Weighted Average Shares Outstanding (Diluted)
 54.33M 40.18M 16.49M 8.40M 5.32M
Currency in USD

Soleno Therapeutics Earnings and Revenue History